The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Performance was driven by strong momentum in Network Solutions, particularly within CERIS, which benefited from accelerated post-payment recoveries and large payer engagements.

Management is observing a market shift from reactive claim correction to proactive payment accuracy, prompting a strategic focus on expanding prepaid solutions.

Patient Management growth reflected stable demand, though results were tempered by targeted investments in personnel and service quality to support new implementations.

Rising claim severity and medical complexity in workers' compensation are driving demand for integrated, outcome-focused models over traditional transactional cost management.

The 'CorVel Connected' interface is being positioned as a unified operating model that integrates real-time data across claims, clinical, and pharmacy workflows.

Operational leverage is being pursued through the deployment of AI-enabled workflow enhancements designed to reduce reliance on manual processes as deployments mature.

The company is rearchitecting the claims process around actionable intelligence, using AI to augment clinical professionals rather than replacing them.

The launch of four large payer programs, including two top 10 national payers, is expected to contribute meaningfully to revenue and profit in the second half of the calendar year.

Management expects personnel levels to normalize as recent implementations mature and automation initiatives are deployed through the remainder of the year and into 2027.

The transition toward prepaid solutions is expected to shorten the revenue realization cycle from over six months to approximately one to two months.

Ongoing investments in AI and API-driven connectivity are intended to improve throughput and ensure regulatory alignment across the evolving healthcare ecosystem.

The company intends to maintain its share repurchase program, funded by strong operating cash flow and a debt-free balance sheet.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

One-time events within CERIS, specifically timing-related post-payment recoveries, added $0.02 to earnings per share during the period.

The effective tax rate increased year-over-year due to the non-recurrence of a discrete benefit from stock option exercises in the prior year.

Management is enhancing governance and resilience initiatives in response to the increasing sophistication of AI-driven cybersecurity vulnerabilities.

General and administrative expenses decreased to 9.4% of revenue, down from 10.6% in the prior year's quarter, aiding margin expansion.